Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Companies / E••••• C•••

E••••• C•••

Stage unknownMountain View, CAPharmaceuticals
Facts
Year of incorporation
unknown
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
2
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
0
Financing history
2 rounds
  1. Oct 31, 2025
    Form D equity offering · $1.2M (form d sold) · 1 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “E••••• C••• filed Form D: $1,200,000 sold of $3,199,991, Pharmaceuticals”
  2. Dec 9, 2024
    Form D equity offering · $4.0M (form d sold) · 1 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “E••••• C••• filed Form D: $3,999,999 sold of $14,999,998, Pharmaceuticals”
Investors on record
0 edges
No named investor yet.
People
1 officers, 6 directors
Timeline
2
  1. Nov 10, 2025
    E••••• C••• filed Form D: $1,200,000 sold of $3,199,991, Pharmaceuticals
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
  2. Dec 20, 2024
    E••••• C••• filed Form D: $3,999,999 sold of $14,999,998, Pharmaceuticals
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
28 observations
Every observation on this company